The evolution of HPV-related anogenital cancers reported in Quebec - Incidence rates and survival probabilities

Chronic Diseases in Canada

Volumn 28, Issue 3, 2008, Pages 99-106

  Louchini, Rabiâ ^a   Goggin, P ^a   Steben, M ^a  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Alphapapillomavirus; Anal neoplasm; Penile neoplasm; Survival probability; Uterine cervical neoplasm; Vaginal neoplasm; Vulvar neoplasm

Indexed keywords

ADULT; AGED; ANUS CANCER; ARTICLE; CANADA; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; GENITAL TRACT CANCER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PENIS CANCER; UTERINE CERVIX CANCER; VULVA CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROBABILITY; QUEBEC; REGISTRIES; SURVIVAL RATE;

EID: 46249116226     PISSN: 02288699     EISSN: 14818523     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 2005;23:2388-94.
2. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24 Suppl 3:S11-S25.
3. Spence AR, Franco EL, Ferenczy A. The Role of Human Papillomaviruses in Cancer. Evidence to Date. Am J Cancer 2005;4:49-64.
4. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monographs 2003;57-65.
5. Melbye M, et al. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994;139:772-80.
6. Maggard MA, Beanes SR, Ko CY. Anal canal cancer: a population-based reappraisal. Dis Colon Rectum 2003;46:1517-23.
7. Johnson LG, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004;101:281-8.
8. Goldman S, et al. Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta chirurgica Scandinavica 1989;155:191-7.
9. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ (Clinical research ed.) 1993;306:419-22.
10. Cheon J, et al. Survey of incidence of urological cancer in South Korea: a 15-year summary. Int J Urol 2002;9:445-54.
11. Levi F, Randimbison L, La Vecchia C. Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994. Ann Oncol 1998;9:1229-32.
12. Maiche AG. Epidemiological aspects of cancer of the penis in Finland. Eur J Cancer Prev 1992;1:153-8.
13. Louchini R. Cancer survival of newly diagnosed cases, 1992: Data quality, fiveyear relative survival rates. Montreal: Institut national de santé publique, Direction du développement et des programmes, Unité connaissance-surveillance, 2002.
14. Duchesne D, et al. Life tables, Canada, provinces and territoies, 1995-1997. Ottawa: Statistics Canada, 2002.
15. Millar WJ, David P. Life tables, Canada and provinces, 1990-1992. Ottawa: Statistics Canada, 1995.
16. Statistics Canada. Life tables, Canada and provinces, 1986. Ottawa: Statistics Canada, 1990.
17. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No.10, End Results Evaluation Section. 1959. National Cancer Institute, Bethesda MD.
18. Louchini R, Beaupré M. Survival probabilities for cancer cases reported between 1984 and 1998 in Quebec: Observed & relative survival. 2003.
19. Cress RD, Holly EA. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med 2003;36:555-60.
20. Diamond C, et al. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005;32:314-20.
21. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol 2002;101:64-9.
22. Joura EA, et al. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000;45:613-5.
23. Sturgeon SR, et al. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992;166:1482-5.
24. Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol 1998;91:969-72.
25. Jones RW, Baranyai J, Stables, S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997;90:448-52.
26. Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 1994;84:741-5.
27. Hatch EE, et al. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control 2001;12:837-45.
28. D.E.S. Action Canada. D.E.S. http://www.web.net/~desact/anglais/anglais. html. 2007.
29. Kalliala I, et al. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ (Clinical research ed.) 2005;331:1183-5.
30. Jeffreys M, et al. Survival from rectal and anal cancers in England and Wales, 1986-2001. Eur J Cancer 2006;42:1434-40.
31. Goggin P, Louchini R, Steben, M. Trends in anal cancer incidence in Quebec. 2005. 22nd International Papillomavirus Conference and Clinical Worshop 2005. Abstract no. P-037.